193 related articles for article (PubMed ID: 12964047)
1. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Sun B; Nishihira J; Suzuki M; Fukushima N; Ishibashi T; Kondo M; Sato Y; Todo S
Int J Mol Med; 2003 Oct; 12(4):633-41. PubMed ID: 12964047
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Sun B; Nishihira J; Yoshiki T; Kondo M; Sato Y; Sasaki F; Todo S
Clin Cancer Res; 2005 Feb; 11(3):1050-8. PubMed ID: 15709171
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways.
Veillat V; Carli C; Metz CN; Al-Abed Y; Naccache PH; Akoum A
J Clin Endocrinol Metab; 2010 Dec; 95(12):E403-12. PubMed ID: 20829186
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways.
Onodera S; Nishihira J; Iwabuchi K; Koyama Y; Yoshida K; Tanaka S; Minami A
J Biol Chem; 2002 Mar; 277(10):7865-74. PubMed ID: 11751895
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
[TBL] [Abstract][Full Text] [Related]
7. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
8. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
9. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
[TBL] [Abstract][Full Text] [Related]
10. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.
Amin MA; Volpert OV; Woods JM; Kumar P; Harlow LA; Koch AE
Circ Res; 2003 Aug; 93(4):321-9. PubMed ID: 12881477
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
Zhang J; Zhang G; Yang S; Qiao J; Li T; Yang S; Hong Y
World J Surg Oncol; 2016 Feb; 14():51. PubMed ID: 26911617
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.
Robinson-White A; Hundley TR; Shiferaw M; Bertherat J; Sandrini F; Stratakis CA
Hum Mol Genet; 2003 Jul; 12(13):1475-84. PubMed ID: 12812976
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages.
Ikeda Y; Murakami A; Ohigashi H
Biochem Pharmacol; 2005 Nov; 70(10):1497-505. PubMed ID: 16188240
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis.
Nishihira J; Ishibashi T; Fukushima T; Sun B; Sato Y; Todo S
Ann N Y Acad Sci; 2003 May; 995():171-82. PubMed ID: 12814949
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.
Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066
[TBL] [Abstract][Full Text] [Related]
19. Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts.
Watanabe H; Shimizu T; Nishihira J; Abe R; Nakayama T; Taniguchi M; Sabe H; Ishibashi T; Shimizu H
J Biol Chem; 2004 Jan; 279(3):1676-83. PubMed ID: 14581488
[TBL] [Abstract][Full Text] [Related]
20. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
